RecruitingPhase 3NCT06665035

A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers

Studying Dengue fever

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Takeda
Principal Investigator
Study Director Study Director
Takeda
Intervention
TDV(biological)
Enrollment
212 enrolled
Eligibility
All sexes
Timeline
20252030

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06665035 on ClinicalTrials.gov

Other trials for Dengue fever

Additional recruiting or active studies for the same condition.

See all trials for Dengue fever

← Back to all trials